Fu Tracy, Stupnitskaia Polina, Matoori Simon
Faculté de Pharmacie, Université de Montréal, Montreal, Quebec H3T 1J4, Canada.
ACS Meas Sci Au. 2022 Jul 12;2(5):377-384. doi: 10.1021/acsmeasuresciau.2c00023. eCollection 2022 Oct 19.
Chronic lower extremity wounds (diabetic foot ulcers) are a serious and prevalent complication of diabetes. These wounds exhibit low healing rates and present a high risk of amputation. Current diagnostic options for foot ulcers are limited to macroscopic wound analysis such as wound depth, implicated tissues, and infection. Molecular diagnostics promises to improve foot ulcer diagnosis, staging, and assessment of the treatment response. In this perspective, we report recent progress in understanding the pathophysiology of diabetic wound healing and point to recently emerged novel molecular targets for wound diagnostics. We discuss selected diagnostic wound dressings under preclinical development that detect one or several inflammatory markers, bacterial secretions, hyperglycemia, and mechanical stress. We also highlight key translational challenges of investigational diagnostic bandages for diabetic foot ulcers.
慢性下肢伤口(糖尿病足溃疡)是糖尿病一种严重且常见的并发症。这些伤口愈合率低,截肢风险高。目前足溃疡的诊断方法仅限于宏观伤口分析,如伤口深度、受累组织和感染情况。分子诊断有望改善足溃疡的诊断、分期以及对治疗反应的评估。从这个角度出发,我们报告了在理解糖尿病伤口愈合病理生理学方面的最新进展,并指出了最近出现的用于伤口诊断的新型分子靶点。我们讨论了处于临床前开发阶段的、可检测一种或多种炎症标志物、细菌分泌物、高血糖和机械应力的精选诊断性伤口敷料。我们还强调了糖尿病足溃疡研究性诊断绷带的关键转化挑战。